Old Web
English
Sign In
Acemap
>
authorDetail
>
Sherye Sirrel
Sherye Sirrel
St. Joseph's Hospital and Medical Center
Thalidomide
Internal medicine
Randomized controlled trial
Psychology
Disease
3
Papers
39
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer’s Disease: Results from a Double-Blind, Placebo-Controlled Trial
2017
Current Alzheimer Research
Boris Decourt
Denise Drumm-Gurnee
Jeffrey R. Wilson
Sandra Jacobson
Christine Belden
Sherye Sirrel
Michael Ahmadi
Holly A. Shill
Jessica Powell
Aaron Walker
Amanda Gonzales
Mimi Macias
Marwan N. Sabbagh
Show All
Source
Cite
Save
Citations (36)
A phase II double-blind, placebo-controlled randomized trial of an escalating dose of thalidomide in the treatment of Alzheimer's disease: Baseline characteristics
2013
Alzheimers & Dementia
Marwan N. Sabbagh
Boris Decourt
Carolyn Liebsack
Sherye Sirrel
Aaron Walker
Amanda Gonzales
Mimi Macias
Sandra Jacobson
Michael Malek-Ahmadi
Christine Belden
Show All
Source
Cite
Save
Citations (0)
Rationale and strategy for thalidomide as a BACE 1 inhibitor for a phase II randomized clinical trial in mild-to-moderate Alzheimer's disease
2010
Alzheimers & Dementia
Marwan N. Sabbagh
Hikmet Nural
Ping He
Sherye Sirrel
Christine Belden
Carolyn Liebsack
Rena Li
Yong Shen
Show All
Source
Cite
Save
Citations (3)
1